Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-08 Sale | 2023-11-08 8:32 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 3,163 | $0.33 | $1,044 | 32,357 (Direct) | View |
| 2023-11-08 Sale | 2023-11-08 8:32 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 3,103 | $0.33 | $1,024 | 23,484 (Direct) | View |
| 2023-11-08 Sale | 2023-11-08 8:31 pm | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 172 | $0.33 | $57 | 32,994 (Direct) | View |
| 2023-11-08 Sale | 2023-11-08 8:31 pm | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 1,811 | $0.33 | $598 | 28,759 (Direct) | View |
| 2023-11-02 Sale | 2023-11-03 4:12 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 6,854 | $0.33 | $2,262 | 47,270 (Direct) | View |
| 2023-11-02 Sale | 2023-11-03 4:11 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 6,854 | $0.33 | $2,262 | 38,587 (Direct) | View |
| 2023-11-02 Sale | 2023-11-03 4:11 pm | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 3,999 | $0.33 | $1,320 | 42,570 (Direct) | View |
| 2023-09-28 Sale | 2023-09-29 4:02 pm | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 1,996 | $3.94 | $7,864 | 121,758 (Direct) | View |
| 2023-08-08 Sale | 2023-08-09 8:44 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 3,128 | $9.51 | $29,747 | 29,874 (Direct) | View |
| 2023-08-08 Sale | 2023-08-09 8:43 pm | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 342 | $9.51 | $3,252 | 20,162 (Direct) | View |
| 2023-08-08 Sale | 2023-08-09 8:42 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 3,434 | $9.51 | $32,657 | 20,941 (Direct) | View |
| 2023-08-08 Sale | 2023-08-09 8:42 pm | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 2,004 | $9.51 | $19,058 | 22,069 (Direct) | View |
| 2023-07-11 Purchase | 2023-07-13 5:15 pm | Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. Flagship Pioneering Inc. Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. AFEYAN NOUBAR 10% Owner | 5,411,255 | $2.31 | $12,499,999 | 4,977,588 (Indirect) | View |
| 2023-05-23 Sale | 2023-06-12 4:01 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 22,571 | $0.1418 | $3,201 | 262,557 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 9:32 pm | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 66,730 | $0.1255 | $8,375 | 97,516 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 9:31 pm | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 68,014 | $0.1255 | $8,536 | 285,128 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 9:31 pm | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 38,531 | $0.1255 | $4,836 | 91,469 (Direct) | View |
| 2023-05-08 Sale | 2023-05-10 9:31 pm | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 3,537 | $0.1255 | $444 | 58,512 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-07 Exercise | 2023-11-08 8:32 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 6,625 | $0 | 32,357 (Direct) | View |
| 2023-11-07 Exercise | 2023-11-08 8:32 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 6,500 | $0 | 23,484 (Direct) | View |
| 2023-11-07 Exercise | 2023-11-08 8:31 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 1,172 | $0 | 32,994 (Direct) | View |
| 2023-11-07 Exercise | 2023-11-08 8:31 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 6,500 | $0 | 28,759 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 4:12 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 12,500 | $0 | 47,270 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 4:11 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 12,500 | $0 | 38,587 (Direct) | View |
| 2023-11-01 Exercise | 2023-11-03 4:11 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 12,500 | $0 | 42,570 (Direct) | View |
| 2023-09-27 Option Award | 2023-09-29 4:02 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 60,000 | $0 | 121,758 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 4:02 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 15,000 | $0 | 121,758 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 8:55 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 8:55 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 8:54 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 37,500 | $0 | 37,500 (Direct) | View |
| 2023-08-07 Exercise | 2023-08-09 8:44 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 6,625 | $0 | 29,874 (Direct) | View |
| 2023-08-07 Exercise | 2023-08-09 8:43 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 1,171 | $0 | 20,162 (Direct) | View |
| 2023-08-07 Exercise | 2023-08-09 8:42 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 6,500 | $0 | 20,941 (Direct) | View |
| 2023-08-07 Exercise | 2023-08-09 8:42 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 6,500 | $0 | 22,069 (Direct) | View |
Ownership | 2023-07-21 7:21 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Horizon Technology Finance Corp 10% Owner | 0 | $0 | 2,164,502 (Direct) | View |
| 2023-07-11 Option Award | 2023-07-12 4:08 pm | N/A 2033-07-11 | Evelo Biosciences Inc. | EVLO | Reynolds Alexander C Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2023-07-11 Option Award | 2023-07-12 4:05 pm | N/A 2033-07-11 | Evelo Biosciences Inc. | EVLO | Moore Jeffrey R. Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:08 pm | N/A 2033-06-08 | Evelo Biosciences Inc. | EVLO | Williams Tonya Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:07 pm | N/A 2033-06-08 | Evelo Biosciences Inc. | EVLO | Gutierrez-Ramos Jose-Carlos Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:06 pm | N/A 2033-06-08 | Evelo Biosciences Inc. | EVLO | Hohneker John Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:06 pm | N/A 2033-06-08 | Evelo Biosciences Inc. | EVLO | McHugh Julie Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:05 pm | N/A 2033-06-08 | Evelo Biosciences Inc. | EVLO | McInnes Iain B. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:04 pm | N/A 2033-06-08 | Evelo Biosciences Inc. | EVLO | MELAS KYRIAZI THEO Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:03 pm | N/A 2033-06-08 | Evelo Biosciences Inc. | EVLO | Andres Juan Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:03 pm | N/A 2033-06-08 | Evelo Biosciences Inc. | EVLO | Rosiello Robert L. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:01 pm | N/A 2033-03-16 | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2023-05-07 Exercise(A) | 2023-05-10 5:11 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 23,437 | $0 | 351,563 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:09 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Thorell Marella Chief Financial Officer | 130,000 | $0 | 520,000 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:09 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | GILL SIMBA President & CEO | 23,437 | $0 | 413,612 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:08 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | Bodmer Mark CSO, President of R&D | 132,500 | $0 | 750,642 (Direct) | View |
| 2023-05-07 Exercise | 2023-05-09 4:08 pm | N/A N/A | Evelo Biosciences Inc. | EVLO | McHale Duncan Chief Medical Officer | 130,000 | $0 | 554,246 (Direct) | View |